Clincosm LogoSign in Get a demo

stage iii esophageal cancer

Showing 1 - 10 of 10
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Stage IV Gastric Cancer, Stage IIIA Gastric Cancer, Stage IIIB Gastric Cancer Trial (basic nutrition, oral supplement of

Not yet recruiting
  • Stage IV Gastric Cancer
  • +4 more
  • basic nutrition
  • oral supplement of creatine and curcumin
  • (no location specified)
May 16, 2023

Acute Myeloid Leukemia, Brain Glioblastoma, Estrogen Receptor Negative Trial in Fullerton (Best Practice, Laboratory Biomarker

Active, not recruiting
  • Acute Myeloid Leukemia
  • +66 more
  • Best Practice
  • +3 more
  • Fullerton, California
    Virginia K Crosson Cancer Center
Jan 31, 2022

Adenocarcinoma of the Esophagus, Adenocarcinoma of the Gastroesophageal Junction, Diffuse Adenocarcinoma of the Stomach Trial in

Terminated
Has Results
  • Adenocarcinoma of the Esophagus
  • +13 more
  • oblimersen sodium
  • +2 more
  • Bronx, New York
    Montefiore Medical Center
Jan 29, 2021

Adenocarcinoma of the Gastroesophageal Junction, Adenocarcinoma of the Stomach, Recurrent Gastric Cancer Trial in Canada, United

Completed
Has Results
  • Adenocarcinoma of the Gastroesophageal Junction
  • +6 more
  • Dalton, Georgia
  • +4 more
Jul 26, 2018

Adenocarcinoma of the Esophagus, Adenocarcinoma of the Gastroesophageal Junction, Adenocarcinoma of the Stomach Trial in

Completed
  • Adenocarcinoma of the Esophagus
  • +7 more
  • erlotinib hydrochloride
  • +10 more
  • Winston-Salem, North Carolina
    Wake Forest University Health Sciences
Jun 29, 2018

Stage II Esophageal Cancer, Stage III Esophageal Cancer Trial in Tianjin (Definitive Radiochemo, Neoadjuvant Radiochemo)

Unknown status
  • Stage II Esophageal Cancer
  • Stage III Esophageal Cancer
  • Definitive Radiochemotherapy
  • Neoadjuvant Radiochemotherapy
  • Tianjin, Tianjin, China
    Department of Radiation Oncology, Tianjin Medical University Can
Jul 13, 2017

Adenocarcinoma of the Esophagus, Adenocarcinoma of the Gastroesophageal Junction, Recurrent Esophageal Cancer Trial in New York

Completed
  • Adenocarcinoma of the Esophagus
  • +5 more
  • erlotinib hydrochloride
  • laboratory biomarker analysis
  • New York, New York
    Memorial Sloan-Kettering Cancer Center
Jun 3, 2013

Advanced Adult Primary Liver Cancer, Anaplastic Thyroid Cancer, Bone Metastases Trial in Columbus (recombinant interleukin-12,

Completed
  • Advanced Adult Primary Liver Cancer
  • +126 more
  • recombinant interleukin-12
  • ABI-007/carboplatin/trastuzumab
  • Columbus, Ohio
    Ohio State University Medical Center
Feb 27, 2013

Adenocarcinoma of the Esophagus, Stage III Esophageal Cancer, Stage IV Esophageal Cancer Trial in Houston (arsenic trioxide)

Terminated
  • Adenocarcinoma of the Esophagus
  • +2 more
  • arsenic trioxide
  • Houston, Texas
    M D Anderson Cancer Center
Jan 22, 2013

Adult Anaplastic Astrocytoma, Adult Anaplastic Ependymoma, Adult Anaplastic Oligodendroglioma Trial in Chicago (erlotinib HCl,

Completed
  • Adult Anaplastic Astrocytoma
  • +85 more
  • erlotinib hydrochloride
  • laboratory biomarker analysis
  • Chicago, Illinois
    Cancer and Leukemia Group B
Jan 15, 2013